A. Asherov

452 total citations
10 papers, 301 citations indexed

About

A. Asherov is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, A. Asherov has authored 10 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in A. Asherov's work include Genetic Neurodegenerative Diseases (6 papers), Muscle Physiology and Disorders (5 papers) and Alzheimer's disease research and treatments (3 papers). A. Asherov is often cited by papers focused on Genetic Neurodegenerative Diseases (6 papers), Muscle Physiology and Disorders (5 papers) and Alzheimer's disease research and treatments (3 papers). A. Asherov collaborates with scholars based in Israel, France and Canada. A. Asherov's co-authors include Amos D. Korczyn, Sergiu C. Blumen, Puiu Nisipeanu, Joab Chapman, Menachem Sadeh, F.M.S. Tomé, T. A. Treves, Bernard Brais, Guy A. Rouleau and Rivka Inzelberg and has published in prestigious journals such as Neurology, Annals of Neurology and Digestive Diseases and Sciences.

In The Last Decade

A. Asherov

10 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Asherov Israel 8 163 153 80 69 52 10 301
Stephan Neudecker Germany 10 170 1.0× 43 0.3× 106 1.3× 59 0.9× 27 0.5× 14 333
J Pouget France 10 87 0.5× 208 1.4× 367 4.6× 62 0.9× 76 1.5× 30 512
Anirban Majumdar United Kingdom 11 193 1.2× 53 0.3× 56 0.7× 61 0.9× 46 0.9× 25 389
Yasuhiro Hijikata Japan 11 188 1.2× 192 1.3× 120 1.5× 206 3.0× 26 0.5× 22 341
M. Kinoshita Japan 14 217 1.3× 198 1.3× 79 1.0× 15 0.2× 35 0.7× 39 393
P Lamberti Italy 8 46 0.3× 44 0.3× 275 3.4× 91 1.3× 30 0.6× 13 371
Takamura Nagasaka Japan 11 106 0.7× 92 0.6× 138 1.7× 25 0.4× 48 0.9× 52 345
Ervina Bilić Croatia 9 52 0.3× 47 0.3× 154 1.9× 69 1.0× 45 0.9× 37 309
Michelle M. Mezei Canada 10 165 1.0× 36 0.2× 158 2.0× 76 1.1× 25 0.5× 19 326
Noriaki Suga Japan 10 135 0.8× 168 1.1× 106 1.3× 165 2.4× 37 0.7× 14 289

Countries citing papers authored by A. Asherov

Since Specialization
Citations

This map shows the geographic impact of A. Asherov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Asherov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Asherov more than expected).

Fields of papers citing papers by A. Asherov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Asherov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Asherov. The network helps show where A. Asherov may publish in the future.

Co-authorship network of co-authors of A. Asherov

This figure shows the co-authorship network connecting the top 25 collaborators of A. Asherov. A scholar is included among the top collaborators of A. Asherov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Asherov. A. Asherov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Blumen, Sergiu C., Amos D. Korczyn, Hugo Lavoie, et al.. (2000). Oculopharyngeal MD among Bukhara Jews is due to a founder (GCG)9 mutation in the PABP2 gene. Neurology. 55(9). 1267–1270. 38 indexed citations
2.
Blumen, Sergiu C., Bernard Brais, Amos D. Korczyn, et al.. (1999). Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Annals of Neurology. 46(1). 115–118. 68 indexed citations
3.
Blumen, Sergiu C., Bernard Brais, Amos D. Korczyn, et al.. (1999). Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease. Annals of Neurology. 46(1). 115–118. 2 indexed citations
4.
Inzelberg, Rivka, Joab Chapman, T. A. Treves, et al.. (1998). Apolipoprotein E4 in Parkinson Disease and Dementia. Alzheimer Disease & Associated Disorders. 12(1). 45–48. 34 indexed citations
5.
Blumen, Sergiu C., Puiu Nisipeanu, Menachem Sadeh, et al.. (1997). Epidemiology and inheritance of oculopharyngeal muscular dystrophy in Israel. Neuromuscular Disorders. 7. S38–S40. 34 indexed citations
6.
Treves, T. A., et al.. (1996). APOE-??4 in Patients with Alzheimer Disease and Vascular Dementia. Alzheimer Disease & Associated Disorders. 10(4). 189–191. 45 indexed citations
7.
Blumen, Sergiu C., Menachem Sadeh, Amos D. Korczyn, et al.. (1996). Intranuclear inclusions in oculopharyngeal muscular dystrophy among Bukhara Jews. Neurology. 46(5). 1324–1324. 25 indexed citations
8.
Treves, T. A., Joab Chapman, Natan M. Bornstein, et al.. (1996). APOE‐ε4 in age‐related memory complaints and Alzheimer's disease. European Journal of Neurology. 3(6). 515–518. 4 indexed citations
9.
Korczyn, Amos D., Aharon Hallak, Jack Baron, et al.. (1996). Esophageal smooth muscle dysfunction in oculopharyngeal muscular dystrophy. Digestive Diseases and Sciences. 41(7). 1350–1354. 11 indexed citations
10.
Blumen, Sergiu C., Puiu Nisipeanu, Menachem Sadeh, et al.. (1993). Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews. Neuromuscular Disorders. 3(5-6). 575–577. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026